Showing 4951-4960 of 5771 results for "".
- Bausch + Lomb Introduces Preservision AREDS 2 Formula Minigel Eye Vitaminshttps://modernod.com/news/bausch-lomb-introduces-preservision-areds-2-formula-minigel-eye-vitamins/2477024/Bausch + Lomb announced the U.S. launch of PreserVision AREDS 2 Formula minigel eye vitamins. The new minigels will replace the currently offered PreserVision AREDS 2 Formula soft gels, offering patients an easier-to-swallow option as compared to the original AREDS 2 soft gels. PreserVision AREDS
- ProQR Receives Rare Pediatric Disease Designation from FDA for Sepofarsen for the Treatment of LCA10https://modernod.com/news/proqr-receives-rare-pediatric-disease-designation-from-fda-for-sepofarsen-for-the-treatment-of-lca10/2477018/ProQR Therapeutics announced that it received Rare Pediatric Disease (RPD) designation from the FDA for sepofarsen for the treatment of Leber’s congenital amaurosis 10 (LCA10), the most common cause of blindness due to genetic disease in children. Sepofarsen (QR-110) is a first-in-class in
- Largest Study of Chinese Americans Uncovers Unique Risk Factors for Visual Impairmenthttps://modernod.com/news/largest-study-of-chinese-americans-uncovers-unique-risk-factors-for-visual-impairment/2477019/CHA Hollywood Presbyterian Medical Center (CHA HPMC) announced publication of a study by Rohit Varma, MD, MPH, director of its Southern California Eye Institute, assessing risk factors for vision impairment in Chinese Americans. The largest study on Chinese Americans to date, “Factors Associated
- World Health Organization to Address its First World Vision Report at Academy 2019 Orlandohttps://modernod.com/news/world-health-organization-to-address-its-first-world-vision-report-at-academy-2019-orlando/2477014/The World Health Organization (WHO) just released its first ever world report on vision, identifying global “significant challenges” in vision health. Today, the American Academy of Optometry (AAO) announced a commitment to rise to those challenges. The first step will occur during the joi
- Eyevance Pharmaceuticals Acquires Tobradex ST and Natacynhttps://modernod.com/news/eyevance-pharmaceuticals-acquires-tobradex-st-and-natacyn/2477011/Eyevance Pharmaceuticals has announced the acquisition of Tobradex ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% and Natacyn (natamycin ophthalmic suspension) 5% from Novartis. Terms of the deal were not disclosed. “The acquisition of Tobradex ST and Natacyn further
- Allergan Shareholders Approve Proposed Acquisition by AbbViehttps://modernod.com/news/allergan-shareholders-approve-proposed-acquisition-by-abbvie/2477010/Allergan announced that its shareholders have voted to approve the previously announced proposed acquisition of Allergan by AbbVie. More than 99 percent of the votes cast at both a special court-ordered meeting of shareholders and at an extraordinary general meeting of shareholders were in favor
- Luneau Technology Acquires Next Sight to Enter Telehealth Markethttps://modernod.com/news/luneau-technology-acquires-next-sight-to-enter-telehealth-market/2477007/Luneau Technology group announced that it has acquired Padova, Italy-based Next Sight, maker of the Nexy retinal screening device. Terms of the deal were not disclosed. The acquisition brings to Luneau increased capabilities–covering both back and front of the eye. Luneau develops,
- Sun Pharma Launches Cequa for the Treatment of Dry Eye Disease in the UShttps://modernod.com/news/sun-pharma-launches-cequa-for-the-treatment-of-dry-eye-disease-in-the-us/2477008/Sun Pharmaceutical announced that its dry eye drug Cequa (cyclosporine ophthalmic solution) 0.09% is now commercially available the United States. Cequa, which offers the highest concentration of cyclosporine for ophthalmic use approved by the FDA, is indicated to increase tear production in pati
- Envision Dallas Lighthouse for the Blind to House American Foundation for the Blind Center on Vision Loss, Esther’s Placehttps://modernod.com/news/envision-dallas-lighthouse-for-the-blind-to-house-american-foundation-for-the-blind-center-on-vision-loss-esthers-place/2477004/Envision announced a collaboration with American Foundation for the Blind (AFB) to establish Envision Dallas Lighthouse for the Blind as the new home of the American Foundation for the Blind Center on Vision Loss and Esther’s Place. A grand opening is expected in spring 2020. Envision Dallas Ligh
- AAO Honors Leaders in Medical and Surgical Eye Carehttps://modernod.com/news/aao-honors-leaders-in-medical-and-surgical-eye-care/2476997/The American Academy of Ophthalmology is honoring ophthalmologists who have improved eye care for millions worldwide through their commitment to their patients and their profession. The honorees will be recognized during AAO 2019, the 123rd Annual Meeting of the American Academy of Oph